These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 310050)

  • 21. Silent substitution S-cone electroretinogram in subjects with diabetes mellitus.
    Mortlock KE; Chiti Z; Drasdo N; Owens DR; North RV
    Ophthalmic Physiol Opt; 2005 Sep; 25(5):392-9. PubMed ID: 16101944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Pföhler C; Tschöp S; König J; Rass K; Tilgen W
    Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    ; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.
    Ong GL; Ripley LG; Newsom RS; Casswell AG
    Br J Ophthalmol; 2003 Jun; 87(6):747-52. PubMed ID: 12770974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between congenital and acquired tritanopia due to diabetic retinopathy.
    Birch-Cox J
    Mod Probl Ophthalmol; 1978; 19():296-8. PubMed ID: 310048
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
    Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
    Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new color vision test to differentiate congenital and acquired color vision defects.
    Shin YJ; Park KH; Hwang JM; Wee WR; Lee JH
    Ophthalmology; 2007 Jul; 114(7):1341-7. PubMed ID: 17296231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of color discrimination changes in diabetic patients without diabetic retinopathy].
    Sun TS; Zhang MN
    Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):41-6. PubMed ID: 23601465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pathogenesis of diabetic dyschromatopsia].
    Gheorghiu M
    Oftalmologia; 1996; 40(1):11-5. PubMed ID: 8714105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Color vision defects in retinitis pigmentosa.
    Fishman GA; Young RS; Vasquez V; Lourenço P
    Ann Ophthalmol; 1981 May; 13(5):609-18. PubMed ID: 6973307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes.
    Andrade LC; Souza GS; Lacerda EM; Nazima MT; Rodrigues AR; Otero LM; Pena FP; Silveira LC; Côrtes MI
    BMC Ophthalmol; 2014 Aug; 14():104. PubMed ID: 25174264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic versus non-diabetic colour vision after cataract surgery.
    Kessel L; Alsing A; Larsen M
    Br J Ophthalmol; 1999 Sep; 83(9):1042-5. PubMed ID: 10460772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colour vision, ophthalmological and linkage studies in a pedigree with a tritan defect.
    Went LN; Völker-Dieben H; de Vries-de Mol EC
    Mod Probl Ophthalmol; 1974; 13(0):272-6. PubMed ID: 4548144
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversible color vision loss in occupational exposure to metallic mercury.
    Cavalleri A; Gobba F
    Environ Res; 1998 May; 77(2):173-7. PubMed ID: 9600811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Positive influence of color experience on result of color-arrangement-test Roth 28-hue (E) desaturated - a clinical study on 44 patients].
    Schröder A; Meinrenken J; Gockeln R; Erb C
    Klin Monbl Augenheilkd; 2002; 219(1-2):33-6. PubMed ID: 11932807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colour vision and light sensitivity in tunnel workers previously exposed to acrylamide and N-methylolacrylamide containing grouting agents.
    Goffeng LO; Kjuus H; Heier MS; Alvestrand M; Ulvestad B; Skaug V
    Neurotoxicology; 2008 Jan; 29(1):31-9. PubMed ID: 17949818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Color vision defects in early diabetic retinopathy.
    Roy MS; Gunkel RD; Podgor MJ
    Arch Ophthalmol; 1986 Feb; 104(2):225-8. PubMed ID: 3484948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.